home / stock / ahksf / ahksf news


AHKSF News and Press, Asahi Kasei Corp

Stock Information

Company Name: Asahi Kasei Corp
Stock Symbol: AHKSF
Market: OTC

Menu

AHKSF AHKSF Quote AHKSF Short AHKSF News AHKSF Articles AHKSF Message Board
Get AHKSF Alerts

News, Short Squeeze, Breakout and More Instantly...

AHKSF - Week In Review: MediLink And BioNTech Form $1.8B ADC Partnership

2024-06-02 03:00:00 ET Summary Suzhou MediLink partners with BioNTech to use its antibody-drug conjugate platform, receiving an upfront payment of $25 million and up to $1.8 billion in milestones. Asahi Kasei offers $1.1 billion to acquire Calliditas Therapeutics, aiming to expand...

AHKSF - Travere gains on Novartis data for Filspari rival, Calliditas buyout

2024-05-28 13:35:36 ET More on Travere Therapeutics Travere Therapeutics, Inc. (TVTX) Q1 2024 Earnings Call Transcript Travere Therapeutics Q1 2024 Earnings Preview Travere, CSL win conditional nod for kidney disease therapy in EU Seeking Alpha’s Quant...

AHKSF - Asahi Kasei To Pay A Fair Price For Calliditas Therapeutics

2024-05-28 10:20:20 ET Summary Asahi Kasei will acquire Calliditas Therapeutics AB (publ) for $1.1 billion, representing an 83% premium to the closing price on the Stockholm exchange and a 74% premium to the Nasdaq closing price. The primary asset of interest in the acquisition is...

AHKSF - Asahi Kasei offers to buy Calliditas Therapeutics for $1.1B

2024-05-28 05:49:18 ET Japanese conglomerate Asahi Kasei ( OTCPK:AHKSY ) ( OTCPK:AHKSF ) on Tuesday proposed to acquire Swedish biopharmaceutical company Calliditas Therapeutics ( NASDAQ: CALT ) for $1.1B.... Read the full article on Seeking Alpha For further det...

AHKSF - Asahi Kasei: Critical Care Should Improve In Margins And Revenues

2024-04-02 11:38:16 ET Summary Asahi Kasei Corporation stock is going to get worse before it gets better, but still has a 14x multiple. Not terribly worthwhile. Its commodity businesses and tapering homes businesses will be offset by critical care, a secularly growing business und...

AHKSF - Asahi Kasei: Not A Bad Proposition

2023-08-03 09:14:44 ET Summary Asahi Kasei in typical Japanese-stock fashion does several totally unrelated things, but has some good positioning in each segment. In materials there is an emerging exposure to renewables. In homes, there are more vigorous overseas markets. In medic...

AHKSF - Adient: A Strong Cash Position Will Allow The Company To Deleverage Its Balance Sheet

Shares of Adient are trading about 57% lower from all-time highs as a result of deteriorating sales and margins. A P/S ratio of 0.275 means the company is trading at very low prices, but this is accompanied by increased risk. The company is overleveraged considering interest expen...

AHKSF - Adient divested its fabrics business for $175M

Adient (ADNT) has closed its previously announced sale of its automotive fabrics manufacturing business, including its lamination business, to Sage Automotive Interiors, an Asahi Kasei Company (AHKSF). The sale aligns with Adient's continuing strategy of focusing on its core, high-volume seat...

AHKSF - Asahi Homes Outperformed, But Along With Other Segments There Are Dark Clouds

Asahi Kasei (AHKSF) is a company we like. Atypical of a Japanese entity, their disclosure is extremely clear, giving very good visibility of what was happening in the business. This visibility was helpful for us to make the assessments that we did in our previous article, where we saw that A...

AHKSF - Sumitomo Chemicals' Non-Pharma Businesses Are Given Essentially No Value By Markets At Current Price

Sumitomo Chemicals, a company under the Sumitomo ( OTCPK:SSUMF ) umbrella, popped onto our radars due to its lingering near-March lows. Unlike other Japanese chemical companies that have seen recoveries like Asahi Kasei ( OTCPK:AHKSF ) and Mitsui Chemicals ( OTCPK:MITUY ), it has hardly reco...

Next 10